首页 | 本学科首页   官方微博 | 高级检索  
检索        

虎杖苷逆转人结肠癌细胞株HT-29奥沙利铂耐药性及机制
引用本文:张冬梅,张雅明.虎杖苷逆转人结肠癌细胞株HT-29奥沙利铂耐药性及机制[J].现代肿瘤医学,2016,0(16):2505-2508.
作者姓名:张冬梅  张雅明
作者单位:上海中医药大学附属曙光医院柏氏肛肠科,上海 200000
基金项目:上海市进一步加快中医药事业发展三年行动计划资助(编号ZY3- CCCX -1-1008)
摘    要:目的:探讨虎杖苷对结肠癌耐药细胞株HT-29奥沙利铂(oxaliplatin,OXA)耐药性的逆转作用并探讨其可能的作用机制。方法:采用逐步增加药物浓度的方法建立奥沙利铂耐药结肠癌细胞株HT-29/OXA。MTT和CCK-8法测定虎杖苷对HT-29/OXA细胞的耐药性逆转作用,流式细胞术检测细胞凋亡、周期变化,qRT-PCR 检测各组细胞LRP(lung resistance protein)和P-gp(P-glycoprotein)mRNA表达水平,Western blot 检测各组细胞LRP和P-gp蛋白的表达水平。结果:虎杖苷使HT-29/OXA细胞对奥沙利铂的敏感性增加,耐药性得到部分逆转(P<0.05)。联合应用对结肠癌耐药细胞株HT-29/OXA生长增殖具有明显抑制作用并且能够通过改变细胞周期引起凋亡(P<0.05)。作用后LRP mRNA和P-gp mRNA表达水平降低,同时下调了LRP和P-gp 蛋白表达(P<0.05)。结论:虎杖苷部分逆转HT-29/OXA细胞对奥沙利铂的耐药性,其机制与降低细胞内LRP基因从而导致P-gp 的表达降低有关。

关 键 词:结肠癌  HT-29  奥沙利铂  多药耐药性  虎杖苷

Polydatin reverses the multi - drug resistance to oxaliplatin in human colon HT - 29 cells
Zhang Dongmei,Zhang Yaming.Polydatin reverses the multi - drug resistance to oxaliplatin in human colon HT - 29 cells[J].Journal of Modern Oncology,2016,0(16):2505-2508.
Authors:Zhang Dongmei  Zhang Yaming
Institution:Department of Anorectal,Shanghai Shuguang Hospital Affiliated of Shanghai University of TCM,Shanghai 200000,China.
Abstract:Objective:To investigate of effect of polydatin on the reversal of multi - drug resistance in HT - 29 /OXA cells and explore its underlying mechanisms. Methods:Oxaliplatin resistant HT - 29 / OXA cells were estab-lished by gradually increase the concentration of oxaliplatin and intermittent treatment with high - dose concentration on parental cells(HT - 29). MTT and CCK - 8 assay were used to detect cell proliferation,flow cytometry was used to detect apoptosis and cell cycle,quantitative real time PCR(qRT - PCR)and Western blot were used to determine the expression levels of lung resistance protein(LRP)and P - glycoprotein(P - gp)mRNA and protein,respective-ly. Results:Oxaliplatin in combination with polydatin significantly inhibited cell proliferation and induced apoptosis with an increase in cell population of G0 / G1 phase in HT - 29 / OXA cells when compared to oxaliplatin or polydatin used alone(P ﹤ 0. 05). HT - 29 / OXA cells received oxaliplatin in combination with polydatin treatment also had a lower expression levels of LRP and P - gp mRNA and protein(P ﹤ 0. 05). Conclusion:Polydatin could partially re-verse the multi - drug resistance to oxaliplatin in HT - 29 / OXA cells,which is related to modulation of LRP and P -gp expression levels.
Keywords:colon cancer  HT - 29  oxaliplatin  multi - drug resistance  ploydatin
本文献已被 万方数据 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号